J.P. Morgan releases its annual look-ahead days before the entire biopharma industry descends on San Francisco for the annual ...

The J.P. Morgan Healthcare Conference attracts thousands of attendees each year from the provider, insurance, digital health ...

J.P. Morgan Asset Management’s Michael Cembalest calls them “Alchemists” — the Trump White House nominees who are looking to ...

J.P. Morgan Chase, with about 300,000 employees worldwide, is expected to announce the end of hybrid and remote work in the ...

The company sought damages against Edward Turley, a former employee who was subject to more than a dozen customer complaints.

Amgen (NASDAQ:AMGN) will present at the 2025 J.P. Morgan Healthcare Conference at 3:00 p.m. PT on Monday, January 13, 2025.

J.P. Morgan analyst Doug Anmuth said he sees room for Alphabet, Google’s parent, to gain ground on a variety of fronts, ...

J.P. Morgan estimates that insured losses from the Los Angeles wildfires could approach $10 billion. The forecasted industry ...

Josh Forstater has joined J.P. Morgan Asset Management as managing director, head of Everyday 401 (k), a retirement plan ...

GlycoNex, Inc. (4168, hereinafter referred to as GNX), a clinical stage biotechnology company focused on the development of glycan-directed cancer immunotherapies, today announced today announced its ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that Brett P. Monia, Ph.D., chief executive officer, will present a company overview at the 43rd Annual J.P. Morgan Healthcare Conference at ...